Jan 25 (Reuters) - Merck is no longer in discussions to buy cancer drug developer Revolution Medicines, the Wall Street ...
The two companies reportedly could not agree on a price, leaving pharma’s first potential megadeal of 2026 on ice.
Judge Royce Lamberth ruled from the bench Monday that evidence provided by the federal government was not sufficient to ...
A federal judge has ruled for a second time in Revoution Wind's favor, lifting a stop-work imposed by the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results